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Nowadays, antimicrobial textile has been widely applied in several sectors, including hospitals 
and healthcare centres, food industry, clothing industry and in domestic environment. 
Antimicrobial textiles are particularly used in active patches and dressings for wound healing, 
infection prevention and control (IPC) articles, deodorization and anti-fungi clothing, among 
other applications. This chapter reviews the characterization, standard testing methods as well 
as existing regulations in Europe and the United States for antimicrobial textiles. Antimicrobial 
textiles were characterized based on their application area. A summary of the efficacy testing 
standards on antimicrobial textiles was presented and critically discussed. Safety evaluation, 
comprising the risk assessment was also introduced. The increasing use of antimicrobial textiles 
is in need of further development of regulations and international testing standards for safety 
and efficacy evaluation in vitro including preclinical testing if applicable. Moreover, particular 
attention was given to the development of durability test standards. 
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Biofilm. 
 
Table of Contents 
1 Introduction  
2 Antimicrobial efficacy testing protocols for antimicrobial textiles  
2.1 Classification and characterization 
2.2 Antimicrobial efficacy testing standards 
2.2.1 Testing standards for antimicrobial active substances 
2.2.2 Testing standards for antimicrobial textiles 
2.3 Safety test 
2.3.1 Pre-testing and risk assessment 
2.3.2 Cytotoxicity 
2.3.3 Irritation and sensitization potential 
2.4 Durability test 
3 Regulations for antimicrobial textiles 







Nowadays, antimicrobial textile has been widely applied in several sectors, including hospitals 
and healthcare centres, food industry, clothing industry and in domestic environment (Espitia 
et al., 2012; Li et al., 2006; Page et al., 2009). The function of antimicrobial treatment may 
differ in diverse areas (Kramer et al., 2006). Generally, when antimicrobial agents are 
incorporated into a textile substrate, two purposes are intended. One, to protect the textile itself 
against bio-deterioration from microbial corrosion for longevity; the other one, which 
represents most of the cases, to provide new properties to protect humans and animals in the 
name of public health as antimicrobial textiles, and odour control (Gutarowska and Michalski, 
2012; Yuan and Cranston, 2008).  
In the critical nosocomial environment, surgical suture has been already incorporated with 
antimicrobial agents, namely triclosan, as a commercial available product decreasing 
postoperative wound complications (i.e. excessive inflammatory response) (Rasic et al., 2011). 
In the surgical practice, there are studies about incorporation of antimicrobial agents in articles 
such as surgical drapes, scrubs, masks, to reduce surgical site infections (SSI) (Li et al., 2006; 
Rozman et al., 2017). In addition, antimicrobial textiles have been extensively applied in wound 
dressing, reducing wound infection due to bacteria colonisation and thereby stimulating healing 
process (Silver et al., 2007; Simões et al., 2018). Numerous wound dressing products containing 
silver ions or silver nanoparticles (AgNPs) can be readily found in the market (Thomas and 
McCubbin, 2003). It is important to denote that healthcare textiles play a sizable role in the 
acquisition and transmission of healthcare-associated pathogens (Mitchell et al., 2015). 
Logically, there is no doubt that antimicrobial textiles can help prevent healthcare-associated 
infections (HCAIs) (Borkow and Gabbay, 2008). As an example, healthcare workers (HCWs) 
uniforms, patients bedsheets, privacy curtains etc. are also gradually being functionalized with 
antimicrobial compounds (Han and Yang, 2005; Schweizer et al., 2015). In the clothing 
industry, antimicrobial textiles are mostly applied for deodorization and anti-fungi action 
(Akira, 1995; Islam et al., 2012). Therefore, they are often found in sport clothes, socks, shoe 
lining, underwear etc.  
Antimicrobial textiles are often achieved by adding antimicrobial agents/substances on textile 
substrates by various chemical or physical means (i.e. build in, after-treatment, or grafting) 
(Liao et al., 2019). The term “antimicrobial” refers to microorganism repellent or reduction of 
microorganism load on the textiles or its surroundings. Therefore, their efficacy is normally 
evaluated by the microorganism reduction through antimicrobial tests. In the development of 
antimicrobial textiles, generally efficacy of both antimicrobial agents and antimicrobial textiles 
as a whole are tested. Several international recognized standards organizations, such as 
European Committee for Normalization (CEN - Comité Européen de Normalisation in French), 
American Society for Testing and Materials (ASTM), International, and American Association 
of Textile Chemists and Colorists (AATCC), Association of Official Agricultural Chemists 
(AOAC), International Japanese Industrial Standards (JIS), International Organization for 
Standardization (ISO) have issued standards for the efficacy test of antimicrobial agents and 
antimicrobial textiles. This chapter encompasses the reviews of both test standards for 
antimicrobial agents and antimicrobial textiles following critical discussion. Most used testing 
standards available in the literature were also summarized and discussed. It is denoted that the 
use of different standards in the evaluation of the antimicrobial efficacy leads to incomparable 
results (Pinho et al., 2010). Also, inadequate selection of antimicrobial test method in vitro 
results in performance discrepancy for similar biocides and textiles (Anderson et al., 2017). 
Since most of the antimicrobial textiles applications are or may be in contact with human body, 
essential safety requirements are need (Seong et al., 1999). Generally, the biocompatibility, 
cytotoxicity, irritation potential, and sensitization are evaluated to fulfil the requirement in the 
regulation. This chapter also takes a look at the regulation side of antimicrobial textile labelling 
in Europe and the United States of America (USA). 
Overall, the chapter mainly answers the following questions regarding antimicrobial textiles:  
1) What are the available testing standards for the antimicrobial efficacy evaluation? 
2) What are the other tests required when considering the safe use of antimicrobial textiles? 
3) What is the current regulation for antimicrobial textiles in Europe and the USA? 
This chapter will guide the researchers and manufacturers selecting the appropriate testing 
methods for their products, ensure sufficient antimicrobial efficacy in situ, while fulfilling the 
regulatory compliance.  
 
2 Antimicrobial efficacy testing protocols for antimicrobial textiles  
 
2.1 Classification and characterization 
 
Before discussing the antimicrobial testing and regulation, it is important to clarify the category 
of antimicrobial textiles. As discussed in the introduction, antimicrobial textiles are defined as 
textiles functionalized with antimicrobials capable of microbial growth inhibition or/and 
biocide activity. A brief mention to microorganism repellent (anti-fouling) will be performed. 
However, the antimicrobial textiles targeting at protecting textile itself are not in the scope of 
this chapter. Such consideration is based on the claim made from the regulatory body (discussed 
elsewhere in the chapter). Based on their antimicrobial mechanisms of action, antimicrobial 
textiles can be divided into the following categories (Sjollema et al., 2018):  
i. Textile capable of control release of antimicrobials;  
ii. Textiles that kill adhering microorganisms directly by contact, without antimicrobial 
compound release (contact killing);  
iii. Textiles that prevent microbial adhesion (anti-fouling). 
The first two referred mechanisms are a proactive approach, being commonly applied in the 
clinical environment and clothing industry due to their ability to actively eliminate or inhibit 
the growth of microbes avoiding their proliferation. In the case of disposable textile products, 
there is no preference between these two mechanisms. However, in the case of reusable textile 
products, the release of antimicrobials from textile material is rather impractical due to the 
laundry process. Therefore, for reusable textile products, immobilization of antimicrobials is 
required. Anti-fouling textiles (category iii) act passively, repelling microorganisms from the 
textile surface through surface modifications, which is not the main focus of this chapter.  
The antimicrobial efficacy testing method in a large extent depends on their antimicrobial 
mechanisms of action and concentration. Furthermore, the regulation differs with the intended 
applications of antimicrobial textiles, as a brief example, wound dressings that will be applied 
in contact with damaged skin tissue possess different requirements than a textile that will 
contact with healthy skin. Thereby, the antimicrobial textile can be divided into three categories 
based on their field of application: 
a. Medical textiles 
b. Hospital textiles  
c. Clothing textiles  
Medical textiles (category a.), are medical devices that come in contact with class 1 sterile tissue 
or vascular system, class 2 mucous membranes or non-intact skin, and class 3 intact skin. 
Typical examples are surgical sutures, surgical drapes, surgical meshes in class 1, wound 
dressing in class 2, and surgical mask, surgical scrubs in class 3. 
Hospital textiles (category b.), comprise healthcare workers’ uniforms, bedlinens, privacy 
curtains in non-critical situations in clinical settings. 
Clothing textiles (category c.), normally refers to antimicrobial textiles application in the 
clothing industry, aiming to reduce the bio-deterioration, malodour, or fungi corrosion. They 
are commonly found in sportswear, underwear, socks, etc. 
 
2.2 Antimicrobial efficacy testing standards 
 
Antimicrobial textiles consist of active textiles which require efficacy tests of antimicrobial 
substances, fabric and their combination, are often required during their development. CEN, 
ASTM, AATCC, AOAC, ISO, Clinical and Laboratory Standards Institute (CLSI), the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST), and Organisation of 
Economic Co-operation and Development (OECD) are international recognized standard 
organizations providing different testing methods based on the intended application and context. 
Other national associations such as JIS and Canadian Standards Association (CSA) also 
stipulate relevant standards for antimicrobial efficacy tests.  
There are numerous variables affecting the antimicrobial efficacy in a testing procedure, namely: 
sample size, inoculum concentration, culture medium or buffer formulation (nutrients 
availability), and these factors vary according different test methods. It is hard to imagine a 
comparable result among all the available test methods (Deshpande et al., 2016; Pinho et al., 
2010). An adequate selection of testing methods plays an important role in leading to a 
successful application for the intended purpose. Many of the testing standards were noted to 
provide a “wet” condition (with a droplet of bacteria inoculum) in the tests, which is rather in 
favour of the antimicrobial efficacy of some antimicrobials (e.g. silver ions) (Liao et al., 2019). 
However, this method does not encompass all real life situations. Humidity, temperature, and 
organic load of the surroundings are critical factors affecting the antimicrobial efficacy of 
antimicrobial textiles.  
In this section, both antimicrobial efficacy testing standards for active substances and 
antimicrobial textiles are introduced.  
 
2.2.1 Testing standards for antimicrobial active substances 
 
Antimicrobial active substances, are chemicals with antimicrobial properties against various 
bacteria, fungi, mycobacterial spores, virus etc. The most commonly used active substances in 
antimicrobial textile application are metal-based antimicrobials composed of metal ions or 
metal nanoparticles (NPs), being the most common: silver, gold, copper, zinc oxide; polymer-
based antimicrobials such as chitosan, quaternary ammonium compounds (QACs); natural-
based antimicrobials, i.e. antimicrobial peptides (AMPs) etc. (Jain et al., 2014; Lemire et al., 
2013; Morais et al., 2016). 
The minimum inhibitory concentration (MIC) test can be used for an initial screening of the 
antimicrobial activity of the active substances (CLSI, 2017; CLSI, 2018a; Watanabe et al., 2019; 
I. Wiegand et al., 2008). There is a high probability that the followed methodology and 
inoculum concentration can significantly influence the result of MIC (Arikan, 2007). For 
biocidal activity assessment, minimum bactericidal concentration (MBC) or minimum 
fungicidal concentration (MFC) is often adopted (CLSI, 1999). Zone of inhibition (ZoI) (also 
known as Kirby−Bauer radial disc diffusion, agar disk diffusion test) is another commonly used 
screen method as a qualitative assessment of the antimicrobial susceptibility (against bacteria 
and fungi) with direct active substances liquid (also known as agar well diffusion method) or 
filter paper disk inoculated with active substances (CLSI, 2018b; CLSI, 2018c) . This method 
is simple to implement, inexpensive, relatively quick and the results are easily visualized 
(Barnard, 2019). However, it is accurately difficult to distinguish the effect between growth 
inhibition or microorganism killing. Therefore, additional tests should be performed. 
When it comes to the antimicrobial efficacy test, the active substances can also be treated as 
disinfectant. CEN Technical Committee (TC) 216 – Chemical disinfectants and antiseptics – 
provides test methods for antimicrobial efficacy evaluation of disinfectants. CEN classifies 
testing standards into 2 phases. Phase 1 refers to suspension tests, giving basic antimicrobial 
evaluation without organic load (bovine albumin fraction V are normally used in the test) for 
generalized use. Phase 2 consists of a 2 step assessment. Phase 2 step 1 is either suspension-
based or carrier-based tests providing options of clean and dirty conditions targeting a more 
specific sector (food, industrial, domestic, institutional areas, medical field, or veterinary areas). 
While Phase 2 step 2 is simulating the practical use of disinfectant and antiseptics in the 
proposed field, such as disinfectant for a hand rub (EN 1500:2013) or disinfectant used with 
mechanical action (EN 16615:2015). Phase 2 step 2 test methods tests the antimicrobial efficacy 
of active substances integrated in other forms. Table 1 below exhibits a summary of CEN 
testing standards appropriate for active substances testing.  
 
Table 1 Testing standards for active substances of antimicrobial textiles from CEN. 




EN 1040:2005 Phase 1 Bacteria  / 
EN 1275:2005 Phase 1 Fungi or yeast  / 
EN 14347:2005 Phase 1 Spores  / 
EN 1276:2019 Phase 2 step 1 Bacteria  
Food, industrial, domestic 
and institutional  
EN 13704:2018 Phase 2 step 1 Spores  
Food, industrial, domestic 
and institutional  
EN 13610:2002 Phase 2 step 1 Virus  
Food, industrial, domestic 
and institutional  
EN 1650:2019 Phase 2 step 1 Fungi or yeast 
Food, industrial, domestic 
and institutional  
EN 
13727:2012+A2:2015 
Phase 2 step 1 Bacteria  Medical 
EN 14348:2005 Phase 2 step 1 Mycobacteria 
Medical (including 
instrument disinfectants)  
EN 17126:2018 Phase 2, step 1 Spores Medical 
EN 
14476:2013+A2:2019  
Phase 2 step 1 Virus  Medical 
EN 13624:2013 Phase 2 step 1 Fungi or yeast Medical 
EN 1656:2019 Phase 2 step 1 Bacteria  Veterinary 
EN 14204:2012 Phase 2 step 1 Mycobacteria Veterinary 
EN 14675:2015 Phase 2 step 1 Virus  Veterinary 
EN 1657:2016 Phase 2, step 1 Fungi or yeast Veterinary 
EN 13623:2010 Phase 2 step 1 Legionella Aqueous systems 
 
2.2.2 Testing standards for antimicrobial textiles  
 
In CEN, (TC) 248 has the responsibility of standardization of textiles, textile products and 
textile components of products in the European Union. Minimum requirements for textiles 
products such as dimension stability, safety design, colour fastness, tensile properties, 
resistance to liquid depending on the final purpose of the textile products etc. are listed in the 
published standards under TC 248. However, in terms of other expected behaviours in a specific 
product, standardization may also be required by other CEN TC. For instance, TC 205 non-
active medical devices working on identifying, adopting, adapting or preparing standards 
supporting applicable European regulations for non-active medical devices such as surgical 
clothing and drapes (EN 13795-1:2019), medical face masks (EN 14683:2019+AC:2019), and 
wound dressing (EN 13726-1/2/3/4) etc. ISO TC 38 is in charge of standardization of textiles. 
However, antimicrobial property is an extra function added to existing textile products. 
Therefore, it is necessary to evaluate the fulfilment of the requirements of both the products 
and antimicrobial efficacy. It is worth to mention that, ASTM has published standard guide for 
the use of standard test methods and practices for evaluating antibacterial activity on textiles 
(ASTM E2922 – 15), which identifies some existing ASTM and other industry standard test 
methods applicable for testing the antibacterial performance on textiles and discusses options 
within each method that have been used to address specific end-use performance expectations 
(2015). There are principally two types of testing methods: qualitative and quantitative. The 
discussed testing methods are listed in Table 2 and 3.  
 
Table 2 Qualitative antimicrobial tests methods for antimicrobial textiles. 
Standard Code Standards/Methods 
AATCC TM 147:2004 
(accredited ISO/IEC 
17025) 
Antibacterial activity assessment of textile materials: parallel streak 
method. 
AATCC TM 90 
Antibacterial activity assessment of textile materials: agar plate 
method 
ASTM E2722 
Test method for using seeded-agar for the screening assessment of 
antimicrobial activity in fabric and air filter media 
JIS L 1902:2008 (Halo 
method) 
Testing for antibacterial activity and efficacy on textile products 
SNV 195920 
Examination of the antimicrobial effect of impregnated textiles by 
the agar diffusion test 
*Swiss Association for Standardization (SNV). 
Table 3 Quantitative antimicrobial tests methods for antimicrobial textiles. 
Standard Code Standards/Methods 
AATCC TM 
100:2004 
Antibacterial finishes on fabrics, evaluation of. (accredited ISO/IEC 17025) 
ASTM E2149-13a 
Test method for determining the antimicrobial activity of antimicrobial 
agents under dynamic contact conditions 
ASTM E2180 
Test method for determining the activity of incorporated antimicrobial 
agent(s) in polymeric or hydrophobic materials 
ISO 20743 
Textiles - determination of antibacterial activity of antibacterial finished 
products 
ISO 22196 Plastics - measurement of antibacterial activity on plastics surfaces 
JIS Z 2801:2000 Antimicrobial products - test for antimicrobial activity and efficacy 
IBRG* 
TEX13/005/1.0 
Quantitative method for evaluating bactericidal 
*International Biodeterioration Research Group (IBRG). 
 
The above-mentioned testing methods were well discussed in ASTM E 2922 – 15, therefore, to 
avoid repetition, only the remaining are presently further discussed. 
 
Qualitative antimicrobial testing methods 
ZoI, previously mentioned, was not only used for active substances testing, but also applied for 
testing fully developed antimicrobial textiles (Hudzicki, 2009). It is one of the most frequently 
used qualitative (or semi-quantitative in specific situations) method for the first step screen of 
antimicrobial activity of antimicrobial textiles. In fact, many aforementioned methods such as 
AATCC TM 147:2004, AATCC TM 90, SNV 195920, and JIS L1902 incorporated the 
principle of ZoI. AATCC TM 30-2004 (Antifungal activity, assessment on textile materials: 
Mildew and rot resistance of textiles) is similar test method but used to test against fungi. 
AATCC TM 174 Part I adapting from AATCC TM 147 against bacteria and Part III adapting 
from AATCC TM 30 against fungi is another test method based on ZoI. ISO 20645:2004 
Textile fabrics — Determination of antibacterial activity — Agar diffusion plate test is another 
example. ZoI-based standards are easy to operate when the specimen is flat (without crimping). 
However, ZoI-based test standards require that antimicrobial active substances are able to 
diffuse from the textile substrate into the agar, which means that it is not suitable for 
immobilized antimicrobial substances. Also, it detects only grow inhibition but not biocidal 
effect. Finally, it should be highlighted that this method is not appropriate for active substances 
that react with the agar or culture medium ingredients.  
 
Quantitative antimicrobial testing methods 
The OECD has published in its series on biocides and testing and assessment a guideline 
document for quantitative method for evaluation antimicrobial activity of porous and non-
porous materials (Ashworth et al., 2014). Porous materials are often referring to textile 
materials. The guideline details the requirements for test methodology, comprising the 
description of test bacteria, preparation of test materials, preparation of the test inoculum, 
inoculation of test materials, incubation, recovery of bacteria from the test samples and 
measurement of colony forming units (CFU), results and test report layout (OECD, 2014). 
Therefore, this chapter will solely refer its establishment and highlight the adequacy of this 
guideline than preforming its copy. In addition, the OECD member countries are encouraged 
to perform the test methods described in the guideline documents for evaluation of 
antimicrobial activity of materials.  
Besides the quantitative methods mentioned in the guideline ASTM 2922-15, another test 
standard ASTM E3160 entitled: quantitative evaluation of the antibacterial properties of porous 
antibacterial treated articles was developed in 2018 (ASTM, 2018). This new test standard is 
able to determine both bactericidal and bacteriostatic activity. 
Besides all the antimicrobial efficacy tests against planktonic microorganisms, it is also of great 
interest of antimicrobial textiles the ability to act against sessile bacteria (biofilm). Biofilm 
comprises accretions of microorganisms enclosed in a self-produced matrix of extracellular 
polymers attached on a surface, representing a robust mode of microbial growth (Hall-Stoodley 
et al., 2004). Increasingly more evidences show the correlation between the existence of biofilm 
and HCAIs, especially in wound infection (Black and Costerton, 2010; Percival et al., 2015). It 
is thereby of great importance for antimicrobial textiles to evaluate their antimicrobial efficacy 
against biofilm. The assessment of biofilm presence and growth in a consistent way is highly 
challenging. Currently, there are five methods developed for biofilm testing with standard 
procedures to evaluate biofilm growth. The methods developed are presented in Figure 1 
(according to their publication dates) (ASTM International, 2013; ASTM International, 2017a; 
ASTM International, 2017b; ASTM International, 2017c; ASTM International, 2019).  
 
Figure 1. Test methods of antimicrobial efficacy against biofilms. 
 
The standard methods allow a consistent biofilm growth and ensure the repeatability and 
reproducibility of the test against biofilm. By modifying the test methods, researchers can study 
factors of interest (e.g. testing surface) (Harrison et al., 2009; Pérez-Díaz et al., 2016). However, 
the test methods involving continuous flow system required expensive lab techniques, more 
complicated to executed unlike the assays with static biofilm systems (Merritt et al., 2011).  
Table 4 depicts antimicrobial efficacy testing method for antimicrobial textiles in literature 
studies. It is noticed that the most often used testing methods are ZoI based protocols, static 




2196 Rotating disk reactor (medium shear and continuous flow) 
ASTM E 
2562
Center for disease control (CDC) biofilm reactor (low shear and 
continuous flow) 
ASTM E 
2647 Drip flow biofilm reactor (low shear and continuous flow) 
ASTM E 
2799
Minimum biofilm eradication concentration (MBEC) (against 
Pseudomonas aeruginosa biofilm)
ASTM 
2871 CDC Biofilm reactor (using the single tube method) 
Table 4 Antimicrobial efficacy test methods in literature studies, describing textile substrate (TS), antimicrobial substances (AMS), and coating 
methods (CM) investigated. 








AATCC TM 100 
(AMT) 
Spun-bond polypropylene 
(PP) (outer layer of 
N95mask) 
Nanoparticles (containing 
silver nitrate and titanium 
dioxide) 
Mathis 2-Roll Type HF-350 textile 
finishing machine (Padding 
machine) 
Surgical masks (Li et al., 2006)  
AATCC TM 100 Melt-blown PP nonwovens 
Gemini surfactant (GS) 
compounds: GS-12-6-12 
Applying a set of porous biocidal 






et al., 2017)  
AATCC TM 100;  




Sol-gel coating with a reactive 
organic-inorganic binder 
N.S. 
(Tomšič et al., 
2008)  
AATCC TM 100 
50 % Polyester (PET) / 




Create covalent bonding form in the 
finishing process of the fabric 
HCWs 
uniforms 









Admicellar polymerization using a 
cationic surfactant 
N.S. 




Wool/acrylic blended yarns 
Rose Bengal (RB) 
photosensitizer 











nanofibers doped with 
montmorillonite (MMT) 
Cationic photosensitizer 
methylene blue (MB) 
Immersion in MB for six days 
following desorption equilibrium 
with phosphate-buffered 
saline solution for around three days 
N.S. 




Para-aramide and PET 
fabric  
Copper (II) 




(Irene et al., 
2016) 
Modified JISL 2801 
100 % PET plain weave 
fabric 
PPy nanoparticles Ultrasound-assisted coating process N.S. 
(Sanchez 







AgNPs deposition by immersion, 
coated with γ-methacryloxypropyl 
trimethoxysilane (MPS) 
N.S. 





Cotton fabric Chitosan derivatives 
Using citric acid (CA) as the 
crosslinking agent (between the 
synthesized chitosan and cotton 
fabric) 
N.S. 
(Fu et al., 
2011) 
Modified ASTM e 
2149-01 
50 % PET/ 50 % cotton 
fabric 
Silver ions Immersion in a ceramic carrier N.S. 
(Condo et al., 
2015) 
JISL1902:2002 Viscose fabric 
Silver nanoparticles 
(AgNPs) 
Sol-gel process following dip 
coating method 
N.S. 
(Mahltig et al., 
2011) 
JIS L 1902: 2002 Alginate Ionic Ag and AgNPs Commercial available 
Wound 
dressing 
(Wiegand et al., 
2009) 
JIS L 1902: 2002 Cotton fabric 
β-cyclodextrin-antiseptic-
complex 













(HSA)/silk fibroin (SF) 
nanocapsules 










ammonium salt based 
nanocomposite 
(OQAS/(Ag/ZnO)) 
Immersion in the nanocomposite 
dispersion, following padding and 
drying process 
N.S. 




(grow in liquid 
broth) 





ZoI Cotton fabric  
Chitosan–silver 
hydrogels 
Padding–squeezing–drying method N.S. 






Gelatin nanofiber mats Antibiotics 




(Dhand et al., 
2017) 
ZoI Cotton fabric Chitosan 
Immersion in a blend of chitosan 
(CS), polyethylene glycol (PEG) and 
polyvinyl pyrolidone (PVP) 
Wound 
dressing 







overnight, padding, PVP coating 
















Viscose/rayon Copper oxide particles 
PP fibres impregnated with 
Copper oxide particles 
Wound 
dressing 
(Borkow et al., 
2010) 
Note: GS-12-6-12 Hexamethylene-1,6-bis(N,N-dimethyl-N-dodecylammonium bromide); N.S. Not specified; MMA Methyl methacrylate; MAA Methacrylic 
acid; MAA1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide EDC/N-hydroxysuccinimide (NHS).
2.3 Safety test  
 
The antimicrobial textile market has increased considerably during the last decade mainly due 
to the advances in biomaterials and nanotechnology (Agnihotri and Dhiman, 2017). This fact 
raised several concerns about the safety of these materials, promoting the development of new 
procedures in biocompatibility tests (Morais et al., 2016). Biocompatibility is an extremely 
important element to ensure that the materials will not cause unwanted biological reactions 
when in contact with human/animal tissues and, consequently, induce the reaction of the host 
immune system (Shah and Dobrovolskaia, 2018). Several methods have been designed to 
determine local and systemic reactions that may present potential toxicological effect and 
objectively evaluate the biological safety of the products and ensure that there are no associated 
health risks (Williams, 2016). The use of antimicrobial materials may cause adverse effects 
owed to chemical and physical reactions associated with the properties of textile surface. 
Therefore, the biocompatibility tests may: i. indicate the chemical and physical interactions 
between the material and the eukaryotic biological tissue and also the eukaryotic biological 
response to these reactions; ii. pin point harmful components of the materials and avoid 
significant adverse effects; iii. establish the potential risk of the material may pose to the user 
(Gad, 2019). In addition, the biocompatibility tests should be performed in the final product 
and not just in the individual components. Even if the individual components do not present 
cytotoxicity, their interaction including any addition during the manufacturing process may 
result in unacceptable biocompatibility results (Tan et al., 2019). Processes like sterilization, 
washing, anodization/passivation and rising may also influence the biocompatibility. Therefore, 
the biocompatibility tests should be performed to the final product, after all the processes are 
adopted during the production (Escudero-Castellanos et al., 2016). 
After a brief explanation about pre-testing, the most common biocompatibility tests will be 
discussed in this section. They are mentioned as “the big three” and include cytotoxicity, 
irritation and sensitization testing. The evaluation of these three biological effects are 
mandatory on medical applications and strongly recommended in other antimicrobial textiles 
applications. However, there are numerous other tests to evaluate the biological effects of 
antimicrobial textiles namely systemic toxicity, genotoxicity, hemocompatibility and 
carcinogenicity (De Jong et al., 2020). The available standards for biocompatibility are 
recommended for the testing of medical devices but they are also applied for the testing of 
antimicrobial textiles in general (Hilgenberg et al., 2016). 
 
2.3.1 Pre-testing and risk assessment  
 
Currently, the biocompatibility testing demands a meticulous planning in order to obtain the 
required results within the shortest time span. The ISO 10993 presents a series of guidelines for 
the biological evaluation of materials to manage the risks of the products for human health and 
safety. The ISO 10993-1 standard (Biological evaluation of medical devices, Part 1: Evaluation 
and testing within a risk management process) was updated in 2018 and provides the pretesting 
considerations about how to plan the biocompatibility tests for materials depending on the 
contact site, contact time and host tissues particularities. It is presented a systematic approach 
to perform a biological evaluation, select the most appropriate methods and propose the risk 
assessment of a product. The standards ISO 10993-18:2020 (Biological evaluation of medical 
devices, Part 18: Chemical characterization of medical device materials within a risk 
management process) and ISO 10993-17:2020 (Biological evaluation of medical devices, Part 
19: Physico-chemical, morphological and topographical characterization of materials) display 
the guidelines for a complete chemical and material characterization to identify and quantify 
the leachable compounds released from the material and understand the basic mechanisms to 
assess the potential cytotoxicological risks. The initial characterization using chemical, physical, 
morphological and topographical methods provide relevant information for risk assessment and 
can support the biocompatibility testing in order to minimize the need for in vivo testing, due 
to its associated costs, time, and animal welfare risks (Brown, 2020; Qin, 2016; ISO, 2018; ISO 
2020a; ISO, 2020b). 
 
2.3.2 Cytotoxicity  
 
Cytotoxicity testing is a primary method for establishing the safety of a material. It allows an 
early assessment of the material destiny, determining if the material can continue further testing, 
or if it requires any modifications, or even, if the martial must be abandoned, all at the initial 
stages of development (Srivastava et al., 2018). The cytotoxicity evaluation of materials 
described in ISO 10993-5:2009 is based in in vitro tests and expresses the toxicological effect 
of the leachable compounds in the material after the incubation of cultured cells in contact with 
the material either directly or through diffusion (De Jong et al., 2020; ISO, 2009). Three 
different methodologies are presented: i. test on extract, ii. test by direct contact and iii. test by 
indirect contact. The first type is the most commonly used technique, where the material is 
immersed in a culture medium, and the fluid extracts are seeded with cells, and after an 
incubation period, the cytotoxicity is assessed. It is extremely useful for soluble substances and 
the results are consistent with the in vivo tests. The extraction solutions (polar and nonpolar) 
should simulate or exaggerate the final use situations to determine any potential toxicity 
(Przekora, 2019). The second method, the direct contact, is highly sensitive, able to detect weak 
cytotoxicity as the samples are directly deposited over cell cultures (Srivastava et al., 2018). As 
for the indirect method, the agar overlay assay, is suitable for material with large toxicity, 
comprising the use of a bulk filter (Li et al., 2015). ISO 10993-12:2012 also regulates the 
samples to test, the control samples (at least one negative and one positive, noncytotoxic or 
cytotoxic response, respectively) and the extraction methodology and preparation. This 
standard also includes a testing plan to guide the operators to the most appropriate test for the 
material to be evaluated (Przekora, 2019). These methods are designed to determine the 
biological response of mammalian cells in vitro using appropriate biological parameters and 
several cell lines are accessible for cytotoxicity testing. Nevertheless, the American Type 
Culture Collection (ATCC) methodology is preferred (De Jong et al., 2020). 
The cytotoxicity can be assessed by the evaluation of cell morphology, cell damage, cell growth 
or by measuring the cellular activity, via quantitative and qualitative methods. Quantitative 
methods include the tetrazolium salt assay (e.g., 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), 3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide (XTT), water-soluble tetrazolium salt (WST-1)), the colony 
formation cytotoxicity test, trypan blue, neutral red uptake and lactate dehydrogenase LDH 
assay. Qualitative analyses include direct contact, morphological grading of cytotoxicity of 
extracts. The combination of the LDH assay to indicate the membrane damage and a metabolic 
activity assay (e.g., tetrazolium salt) is frequently used (Liu et al., 2018; Iqbal and Keshavarz, 
2017; Sampaio et al., 2016).  
 
2.3.3 Irritation and sensitization potential 
 
Assessment of potential allergic reactions, namely irritation and sensitization, belongs to the 
basic set of toxicology tests of antimicrobial textiles. An irritation reaction occurs immediately 
after the first exposure and is a non-immunologic local inflammatory reaction caused by 
external stimuli. The sensitization reaction only takes place after repeated or prolonged 
exposure and is independent of the dose. A slight exposure may cause a severe or even possibly 
lethal toxic reaction, inducing vesiculation or necrosis, and may be systemic. These 
characteristics may hinder the perception of the toxic reaction (Park et al., 2018). ISO 10993-
10:2010 describes the in vitro, in silico and in vivo methods for the assessment of materials with 
regard to their potential to produce irritation and skin sensitization. It evaluates the possible 
contact hazards from chemicals released from textile materials that may produce irritation of 
the skin, mucosal and eye or skin sensitization. The initial in vitro methods are recommended 
for the initial screening prior to animal testing. Despite the numerous information extracted 
from in vitro testing results, an animal test is usually required prior to human testing (ISO, 
2010). According to ISO 10993-10, there are in vitro and in vivo methods available for irritation 
evaluation. However, the in vitro test for skin irritation has been validated just for neat 
chemicals. Therefore, antimicrobial textiles have to be tested using in vivo methods. The active 
and control samples are deposited directly in the skin of healthy rabbits and the appearance of 
each application site (redness and swelling) is evaluated in terms of erythema and eschar 
formation after 1, 24, 48, and 72 h. The skin irritation degree (from negligible to severe) of the 
material is determined by hematoxylin and eosin (H&E) stained images (Gu et al., 2018). After 
this, human studies can be carried out due to the discrepancies from animal and human skin 
irritation reactions. The human tests are only permitted if the material had no negative effects 
in previous animal tests (Hilgenberg et al., 2016; Qin, 2016). 
Sensitization testing, also presented in ISO 10993-10:2010, is based on in vivo tests to assess 
the ability of leachable compounds to prompt skin hazards. To help to investigate whether a 
material contains chemicals that cause antagonistic effects after repeated or prolonged exposure 
four methods are commonly used, namely: murine local lymph node assay (LLNA), Guinea pig 
assay, Guinea pig maximization test (GPMT) and closed-patch test (Buehler test) (ISO, 2010). 
The LLNA was the first alternative method to experience formal validation for skin 
sensitization hazard tests. It is a useful tool to measure the relative potency of skin sensitizing 
chemicals and presented extreme utility in terms of driving improvements in risk assessment, 
risk management and protection of human health (Basketter et al., 2017). The other models 
(Guinea pig assay, GPMT and Buehler test) are animal models with invaluable relevance to the 
study of allergic and toxicological reactivity. Guinea pig models are among the most frequently 
used methods. The GPMT is usually considered the most sensitive procedure to detect the 
capacity of a substance to induce contact hypersensitivity, and is among the best methods to 
extrapolate the results to humans and may also be used to elucidate dose-response relationships. 
However, due to the ethical issues and concerns about animal well-being, a multi-phase 
program is required to develop a non-animal method with regulatory acceptance to predict skin 
sensitization (Hoffmann et al., 2018; Modjtahedi et al., 2011). 
 
2.4 Durability test  
 
Durability of antimicrobial textiles refers to the desired physical durability and chemical 
stability over a specific time of use. It is especially important for reusable textiles, such as 
uniforms, bedlinen, privacy curtains, towels, etc. that still maintain sufficient antimicrobial 
efficacy after laundry (exposure to detergent and high temperature). Physical durability, namely 
resistance to tear, abrasion etc. is identical comparable requirements to other textile products. 
Giving as an example, CEN/TC 248 Working Group 16 Textiles in healthcare system issued 
the technical specification for textile products used for healthcare and social services facilities 
(Ref. No. CEN/TS 14237:2015) indicating characteristics, test method and minimum 
performance properties of textile products intended to be used after industrial laundering (CEN, 
2015). However, in this chapter, the durability of the antimicrobial textiles will focus on the 
antimicrobial efficacy performance.  
Many studies started paying attention to the durability of antimicrobial efficacy in the 
development of new antimicrobial textiles (Fu et al., 2011; Gao et al., 2019; Shahid-Ul-Islam 
and Butola, 2019). The durability study of antimicrobial textiles normally combines the 
simulation of the laundering process with an antimicrobial test. Existing standards/methods 
simulating home or industrial laundry process for textile products were implemented for 
reproducibility and consistency of the research work. 
AATCC has established monography of Standardization of hand laundering for fabrics and 
apparel and standardization of home laundry test conditions for test methods utilizing laundry 
procedures (such as AATCC TM 124, 135, 143, 150) in the technical manual. The guideline 
listed detailed parameter settings of type of machine, temperature, water level etc. of laundering, 
drying, and restoring. Also, “1993 AATCC Standard reference detergent and laundry detergents 
in general” and “2003 AATCC Standard reference liquid laundry detergent” were developed, 
listing the comparable reference detergent to powder and liquid laundry detergent in the market. 
However, the specimen size required in the monography is relatively large, which is not 
favourable for the testing of antimicrobial textiles which generally comprise small specimens. 
Therefore, accelerated washing procedure developed in AATCC test methods can be an 
alternative, AATCC TM 61 Colorfastness to laundering: accelerated, where five typical home 
laundering processes are recommended. This test method is similar to EN ISO 105-C06, 
Textiles - tests for colour fastness - Part C06: Colour fastness to domestic and commercial 
laundering (accredited from ISO 105-C06). Unfortunately, industrial laundering procedure is 
not covered in AATCC since TM 87-1965 Colorfastness to washing, industrial laundering: 
accelerated is discontinued. 
 ISO/TC 38/SC 2 Cleansing, finishing and water resistance tests cover the standards providing 
exacting laboratory settings of textile domestic and industrial laundry procedures under 
standardized conditions. ISO 6330, Textiles - domestic washing and drying procedures for 
textile testing and ISO 15797:2017 Textiles - industrial washing and finishing procedures for 
testing of workwear (labelling workwear to be industrially laundered) are the given examples. 
CEN has also adopted the ISO standards previously mentioned for domestic and industrial 
washing testing in the laboratory setting. Other national standards, such as CSA Z314. 10-03 
(selection use, maintenance and laundering or reusable textile wrappers, surgical gowns, and 
drapes for heal care facilities) and JIS L 1930 Textiles - domestic washing and drying 
procedures for textile testing can also be used as a reference laundry procedure.  
There is also a new developed protocol from ASTM E3162-18, Standard practice measuring 
the durability of antibacterial agents applied to textiles under simulated home laundering 
conditions, which can determine the durability of standard antimicrobial treatment on textiles 
undergoing multiple home laundering cycles (ASTM, 2018). Table 5 exhibits the durability 
tests of antimicrobial textiles performed in the literature. Notably, many studies developed their 
simulation of washing process in the study and some are even poorly described (Xing et al., 
2007). It is suggested using standard washing procedure while evaluating the durability of 
antimicrobial textiles in research, to ensure consistent and comparable result with the others. 
The standard washing process developed by AATCC, ISO etc. can in a large extent simulate 
the laundry process in reality (either domestic or industrial) with laboratory settings, which is 
supportive in understanding or predicting the performance of antimicrobial textiles in 
field/practice. 
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well described) 
1/5/10/20/50 N.S. 
(Xing et al., 
2007) 
*AEGIS: 3-(trihydroxysilyl) propyldimethyloctadecyl ammonium chloride. 
N.S.: not specified 
3. Regulations for antimicrobial textiles 
 
This section of the chapter will mainly introduce the regulatory issue regarding antimicrobial 
textiles market, distribution, and applications in the EU and USA. It is worth mentioning that 
antimicrobial textiles have to  follow the regulation compliance as a basic requirement in their 
development. Requirements change depending on the claim of the products documented in the 
regulatory body. 
Antimicrobial textiles based on their final application purposes differs in the claim and labelling. 
In EU, antimicrobial textiles with the aim of protecting textiles or odour prevention are 
categorized as treated articles. While antimicrobial textiles with a primary biocidal function, 
especially with a public healthcare relevance are considered as biocidal products (i.e. 
antimicrobial textiles applied in hospitals for infection prevention and control) (ECHA, 2018). 
Both treated articles and biocidal products are covered by the rules and obligations issued by 
the Biocidal Product Regulation (BPR). However, a biocide product requires an extra step 
“authorisation” than treated articles before they can be placed in the EU market. The assessment 
of antimicrobial textiles whether as treated articles or biocidal products should be consulted by 
treated articles guideline “CA-Sept13-Doc.5.1.e (Rev.1)” (European Commission, 2014). 
When the antimicrobial textiles contain nanoparticles, specific requirements for nanomaterials 
are demanded. Those provision defined by BPR apply for active and non-active substances with 
the following characteristics (ECHA, 2020): 
 
• 50 % or more of the particles have a size between 1-100 nanometres in at least one 
dimension 
• Particles are in an unbound state or as an aggregate or agglomerate 
 
The active substances incorporated in antimicrobial textiles are considered as biocides. In the 
EU market, biocidal active substances can only be placed in the market with approval or under 
review since March, 1st 2017. The list of approved active substances supplier is enclosed in 
Article 95. Further biocidal products legislations can be consulted according to biocidal 
products directive (Directive 98/8/EC) or Regulation (EU) No 528/2012 of the European 
Parliament and of the Council (Council of the European Union, 2012).  
Additionally, manufacturers and importers of chemicals in the EU market are obliged to fulfil 
the regulatory framework from Registration, Evaluation, Authorisation and Restriction of 
Chemicals (REACH) for each substance (including nanomaterials) manufactured or imported 
in quantities of 1 tonne or higher per year per company (legal entity) (EPC, 2007). 
In the USA, Environmental Protection Agency (EPA) is responsible for antimicrobial textiles 
regulatory issues under the statutory authority of the Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA). Office of Pesticide Programs (OPP) from EPA categorises 
antimicrobial textiles into two groups, treated articles and antimicrobial pesticides. Treated 
articles claim indicates that the antimicrobial incorporated into textile is intended to protect 
textile from microbial deterioration and thereby can be applied to “treated articles exemption" 
in 40 CFR 152.25(a) (Federal insecticide, fungicide, and rodenticide act, 2000). While the other 
antimicrobial textiles, categorized as antimicrobial pesticide products, follow the registration 
process together with risk assessment. Furthermore, antimicrobial pesticide products can be 
classified as either “public health” or “non-public health” claims. With public health claim, 
efficacy data to support their intended application must be submitted. Typical antimicrobial 
hospital textiles with intension of infection control and prevention are normally claimed for 
“public health”. Antimicrobial textiles with odour control is an example of antimicrobial 
pesticide with “non-public health” claim. However, in the case of microorganism repellent, 
which controls the microorganism by physical or mechanical actions, does not require EPA 
registration.  
Whereas, regulation becomes more stringent when the antimicrobial textiles are classified as 
medical devices, such as wound dressings, surgical masks, surgical drapes. For instance, wound 
dressings combined with drugs (also known as antimicrobial wound dressings) will be regulated 
as combination products and thereby applies to the rules by USA Food and Drug administration 
(FDA). The classification of medical devices (wound dressing in the application of 
antimicrobial textiles) are defined as Class I that are subject only to general controls; Class II 
subject to general and special controls; and Class III subject to premarket approval) based on 
their intended use, safety and risk (21 CFR 878.4015) (FDA, 2019). Wound dressing intended 
to accelerate the wound healing will be considered as Class III; while wound dressing with 
antimicrobial agents minimizing microbial growth are normally encompassed by Class II (FDA, 
2016). To comply with Class II requirements  performance standards test, postmarket 
surveillance, patient registries and/or development of guidelines, and reasonable assurance of 
safety and effectiveness may be required (FDA, 2009). 
It is noticed from the review of the regulation that the legislation of antimicrobial textiles is 
complex and expensive. Regulation can be more stringent when the antimicrobial textiles are 
classified as medical devices, such as wound dressings, surgical masks, surgical drapes. It is 
one of the reasons hampering the translation of advanced research of antimicrobial textiles 
downward to the market. However, thinking of the final products in the market, researchers 
may also take into account the regulation aspect in the development of new antimicrobial 




The development of novel antimicrobial textiles has obtained great interest due to the growing 
need to maintain the longevity of textiles, control the odour, wound management, and infection 
prevention and control. Therefore, the increasing use of antimicrobial textiles is in need of 
further development of regulations and international testing standards for safety and efficacy 
evaluation, including preclinical testing if applicable. Reproducibility and simulation of field 
testing should be the focus of the newly developed testing standards. Tests performed in 
different facilities or with different method display different results. Also, there is a lack of 
consistency between the bench test (in vitro) and field study result. Antimicrobial textile 
performance discrepancy was often observed between the research stage and their application 
in situ. Especially in clinical application, the question of how to ensure the clinical success 
during the application of antimicrobial textiles still remains. Therefore, new in vitro testing 
methods should seek to predict the actual in situ performance of antimicrobial textiles. 
Furthermore, particular attention should be given to the development of durability test standards. 
In addition, relevant safety tests, namely cytotoxicity, irritation potential and sensitization 
should be evaluated during the development of antimicrobial textiles. Depending on the 
envisaged antimicrobial textiles claim, corresponding regulation should be considered and 
consulted to facilitate their final launch in the market. It should be denoted that the main reasons 
hindering the development of novel advanced antimicrobial textile are the lack of sufficient 
testing standards and the complex and expensive regulatory procedures. 
The application of antimicrobial textiles in clinical settings have an unquestionable potential to 
prevent and control nosocomial infections. However, there is still a lack of detailed studies 
describing if their applications may promote the development of multidrug-resistant organisms 
(MDROs). Finally, there is still a grievous insufficient development of novel antimicrobial 
textiles focused on anti-biofilm activity and virus, despite their recognized public health 
menacing nature. Hopefully, this will swiftly change in a near future.  
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